Ferric maltol
Accrufer, Feraccru (ferric maltol) is a small molecule pharmaceutical. Ferric maltol was first approved as Accrufer on 2016-02-18. It has been approved in Europe to treat iron-deficiency anemia. Accrufer's patent is valid until 2035-10-23 (FDA).
| Trade Name | Feraccru |
|---|---|
| Common Name | Ferric maltol |
| Indication | iron-deficiency anemia |
| Drug Class | Hematologic agents |
